1057: How low can the dose of ketamine for analgesia in the ED go?
Show notes at pharmacyjoe.com/episode1057. In this episode, I’ll discuss two doses of ketamine for analgesia in the ED. The post…
AMCP CEO: Pharmacists’ Communication, Trust-Building Key to Addressing Vaccine Hesitancy
Susan Cantrell, RPh, MHL, CAE, CEO of the Academy of Managed Care Pharmacy, stresses the importance of listening, empathy, and…
Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
For pharmacists, understanding the evolving therapeutic landscape is essential—not only to optimize drug selection and dosing but also to counsel…
Protecting Community Oncology Practices in the Wake of the IRA
Explore the impact of the Inflation Reduction Act on community oncology practices and discover how new legislation aims to protect…
Expert: Pharmacists Play Key Role in Expanding RSV Vaccine Awareness, Adult Immunization Efforts
Alyssa Modic, PharmD, discusses the evolving role of pharmacists in adult immunizations and strategies to improve respiratory syncytial virus (RSV)…
Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk
An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.
FDA Approves 3-Month Leuprolide Mesylate 21 mg Formulation for Advanced Prostate Cancer
The FDA has approved a ready-to-use long-acting injectable formulation that is administered every 3 months as a treatment for advanced…
Many Patients With Statin Intolerance Self-Medicate, Despite No Link to Lowering LDL-C
Self-medication, including the use of dietary supplements and pain relief drugs, were reported by many patients with statin-associated muscle symptoms…
Rising 340B Costs Drive Employer Spending and Spark Calls for Reform
Employers are facing higher costs and employees higher premiums as 340B’s growth drives lost rebates and rising drug prices.
Abemaciclib Plus Endocrine Therapy Improves Survival in Patients With HR+/HER2– Breast Cancer
Abemaciclib enhances overall survival in high-risk HR+, HER2– early breast cancer, establishing its role as a standard adjuvant therapy.